These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21989892)

  • 1. Influence of estrogen on pulmonary arterial hypertension: role of oxidative stress.
    Siqueira R; Campos C; Colombo R; Becker CU; Fernandes TR; Araújo AS; Belló-Klein A
    Cell Biochem Funct; 2011 Oct; 29(7):543-8. PubMed ID: 21989892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ovariectomy on antioxidant defence systems in the right ventricle of female rats with pulmonary arterial hypertension induced by monocrotaline.
    Siqueira R; Colombo R; Conzatti A; de Castro AL; Carraro CC; Tavares AMV; Fernandes TRG; Araujo ASDR; Belló-Klein A
    Can J Physiol Pharmacol; 2018 Mar; 96(3):295-303. PubMed ID: 28854338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the time course of pulmonary arterial hypertension with changes in oxidative stress in the left ventricle.
    Leichsenring-Silva F; Tavares AM; Mosele F; Berger B; Llesuy S; Belló-Klein A
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):804-10. PubMed ID: 21923751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats.
    Tofovic PS; Zhang X; Petrusevska G
    Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
    Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Free and Nanoencapsulated Copaiba Oil on Monocrotaline-induced Pulmonary Arterial Hypertension.
    Campos C; de Castro AL; Tavares AM; Fernandes RO; Ortiz VD; Barboza TE; Pereira C; Apel M; da Silva OS; Llesuy S; Araujo AS; Belló-Klein A
    J Cardiovasc Pharmacol; 2017 Feb; 69(2):79-85. PubMed ID: 27798416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats.
    Campos-Carraro C; Turck P; de Lima-Seolin BG; Teixeira RB; Zimmer A; Araujo ASDR; Belló-Klein A
    Can J Physiol Pharmacol; 2023 Sep; 101(9):447-454. PubMed ID: 37581356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.
    Wang Y; Tian W; Xiu C; Yan M; Wang S; Mei Y
    Clin Rheumatol; 2019 Jan; 38(1):29-35. PubMed ID: 29362961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glycoltic metabolism gene changes in left and right ventricles in experimental rat pulmonary arterial hypertension model].
    Qiu M; Zhang R; Zheng Y; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1010-6. PubMed ID: 25623347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats.
    Bal E; Ilgin S; Atli O; Ergun B; Sirmagul B
    Hum Exp Toxicol; 2013 Jul; 32(7):766-74. PubMed ID: 23821593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Zopf DA; das Neves LA; Nikula KJ; Huang J; Senese PB; Gralinski MR
    Eur J Pharmacol; 2011 Nov; 670(1):195-203. PubMed ID: 21914448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-nitroso human serum albumin attenuates pulmonary hypertension, improves right ventricular-arterial coupling, and reduces oxidative stress in a chronic right ventricle volume overload model.
    Rungatscher A; Hallström S; Linardi D; Milani E; Gasser H; Podesser BK; Scarabelli TM; Luciani GB; Faggian G
    J Heart Lung Transplant; 2015 Mar; 34(3):479-88. PubMed ID: 25511748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent therapeutic effects of 2-Methoxyestradiol on Monocrotaline-Induced pulmonary hypertension and vascular remodelling.
    Tofovic SP; Jones T; Petrusevska G
    Prilozi; 2010; 31(1):279-95. PubMed ID: 20693947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats.
    Tang B; Chen GX; Liang MY; Yao JP; Wu ZK
    Int J Cardiol; 2015 Feb; 180():134-41. PubMed ID: 25438234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.